Company Filing History:
Years Active: 2004
Title: Zigang Dong: Innovator in Cancer Treatment
Introduction
Zigang Dong is a prominent inventor based in Frederick, MD (US). He has made significant contributions to the field of cancer research through his innovative work. His research focuses on the mechanisms of cancer prevention and treatment, particularly through the inhibition of specific cellular activities.
Latest Patents
Zigang Dong holds a patent for "Dominant negative deletion mutants of C-jun and their use in the prevention and treatment of cancer." This patent discloses the inhibition of AP-1 activity by dominant negative deletion mutants of c-jun. The invention demonstrates that this inhibition is associated with the prevention of tumor promoter-induced neoplastic transformation. Therefore, his work relates to the use of these mutants as therapeutic agents in the prevention and treatment of cancer in mammals.
Career Highlights
Zigang Dong is affiliated with the National Institutes of Health, a component of the US Department of Health & Human Services. His role at this esteemed institution allows him to contribute to groundbreaking research in cancer treatment and prevention. His work has garnered attention for its potential impact on therapeutic strategies.
Collaborations
Zigang Dong has collaborated with notable colleagues, including Nancy H. Colburn and Powel H. Brown. These collaborations have further enriched his research and expanded the scope of his contributions to cancer treatment.
Conclusion
Zigang Dong's innovative work in cancer research exemplifies the importance of scientific inquiry in developing effective treatments. His patent on dominant negative deletion mutants of c-jun highlights his commitment to advancing medical science. Through his career at the National Institutes of Health, he continues to make strides in the fight against cancer.